Correlation Between Ensysce Biosciences and NLS Pharmaceutics

Can any of the company-specific risk be diversified away by investing in both Ensysce Biosciences and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ensysce Biosciences and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ensysce Biosciences and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Ensysce Biosciences and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ensysce Biosciences with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ensysce Biosciences and NLS Pharmaceutics.

Diversification Opportunities for Ensysce Biosciences and NLS Pharmaceutics

-0.46

Correlation Coefficient

Ensysce Biosciences  NLS Pharmaceutics

Very good diversification

The 3 months correlation between Ensysce and NLS is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Ensysce Biosciences and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Ensysce Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ensysce Biosciences are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Ensysce Biosciences i.e., Ensysce Biosciences and NLS Pharmaceutics go up and down completely randomly.

Pair Corralation between Ensysce Biosciences and NLS Pharmaceutics

Given the investment horizon of 90 days Ensysce Biosciences is expected to under-perform the NLS Pharmaceutics. But the stock apears to be less risky and, when comparing its historical volatility, Ensysce Biosciences is 1.26 times less risky than NLS Pharmaceutics. The stock trades about -0.04 of its potential returns per unit of risk. The NLS Pharmaceutics AG is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  171.00  in NLS Pharmaceutics AG on May 4, 2025 and sell it today you would earn a total of  9.00  from holding NLS Pharmaceutics AG or generate 5.26% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Ensysce Biosciences  vs.  NLS Pharmaceutics AG

Ensysce Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ensysce Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

NLS Pharmaceutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in NLS Pharmaceutics AG are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, NLS Pharmaceutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ensysce Biosciences and NLS Pharmaceutics

The main advantage of trading using opposite Ensysce Biosciences and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ensysce Biosciences position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.

The idea behind Ensysce Biosciences and NLS Pharmaceutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.